“This document serves to emphasize international consensus regarding MHT and is aimed at empowering women and healthcare practitioners in the…”.1

Umbrella
What may the Hormone Therapy 2013 Global Consensus Statement Umbrella include?

Depending on the Source (DotS) this Umbrella may include:

  • Global Consensus Statement on Menopausal Hormone Therapy
  • Hormone Replacement Therapy (HRT)
  • Hormone Therapy (HT)
  • Menopausal Hormone Therapy (MHT)

Background

What is the background for the Global Consensus Statement on Menopausal Hormone Therapy?

In the Global Consensus Statement on Menopausal Hormone Therapy published in 2013, the authors elaborate on:

“…The International Menopause Society took the initiative to arrange a round-table discussion, in November 2012, between representatives of the major regional menopause societies to reach consensus on core recommendations regarding MHT”.2

What is MHT?

MHT can be an abbreviation for Menopausal Hormone Therapy.

Organizations

Which organizations endorse the Global Consensus Statement?

Organization which endorse the Global Consensus Statement (in alphabetical order) are the:

Organizations

  1. American Society for Reproductive Medicine
  2. Asia Pacific Menopause Federation
  3. Endocrine Society
  4. European Menopause and Andropause Society
  5. International Menopause Society
  6. International Osteoporosis Foundation
  7. North American Menopause Society

Aim

What is the aim of the Global Consensus Statement?

In Global Consensus Statement on Menopausal Hormone Therapy published in 2013, the authors explain:

“The aim was to produce a short document in bullet-point style, only containing the points of consensus”.3

Acknowledgement

What did the Global Consensus Statement acknowledge?

The authors of the Global Consensus Statement acknowledge:

“It is acknowledged that, in view of the global variance of disease and regulatory restrictions, these core recommendations do not replace the more detailed and fully referenced recommendations prepared by individual national and regional societies. This document serves to emphasize international consensus regarding MHT and is aimed at empowering women and healthcare practitioners in the appropriate use of MHT”.4

Consensus

What are some points of consensus in the Global Consensus Statement?

Some points of consensus are:

  • “MHT is the most effective treatment for vasomotor symptoms associated with menopause at any age, but benefits are more likely to outweigh risks for symptomatic women before the age of 60 years or within 10 years after menopause
  • MHT is effective and appropriate for the prevention of osteoporosis-related fractures in at-risk women before age 60 years or within 10 years after menopause
  • Local low-dose estrogen therapy is preferred for women whose symptoms are limited to vaginal dryness or associated discomfort with intercourse”.5

Vasomotor Symptoms

What are vasomotor symptoms?

DotS the definition of vasomotor symptoms may vary. The North American Menopause Society’s definition is:

“Vasomotor symptoms. Also known as hot flashes and night sweats, common symptoms during perimenopause and early postmenopause”.6

Review

Is the Global Consensus Statement to be reviewed?

The authors of the Global Consensus Statement note:

“These core recommendations will be reviewed in the future as new evidence becomes available”.7

Revised Global Consensus Statement

When was the Revised Global Consensus Statement on Menopausal Hormone Therapy published?

The Revised Global Consensus Statement on Menopausal Hormone Therapy was published online 20 June 2016.

Health Care Provider

What if I choose to use MHT?

If you choose to use MHT, it may be in your best interest to also choose to talk to your health care provider about this.

One of the points of consensus in the Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT published in 2016, is:

  • “The option of MHT is an individual decision in terms of quality of life and health priorities as well as personal risk factors such as age, time since menopause and the risk of VTE, stroke, ischemic heart disease and breast cancer. MHT should not be recommended without a clear indication for its use”.8

Health Topics A-Z

Where may I find Health Topics related to Hormone Therapy 2013 Global Consensus Statement?

In Health Topics A-Z you may find:

Links

Where may I find Links related to Hormone Therapy 2013 Global Consensus Statement?

Your Country may have Links similar to:

Sources

Where may I find the Sources quoted?

You may find the Sources quoted at:

Sources

  1. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/manage/images/pdf/097326f9db0697ef9a6707fc97fd2468.pdf Accessed: 08 October 2020
  2. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/manage/images/pdf/097326f9db0697ef9a6707fc97fd2468.pdf Accessed: 08 October 2020
  3. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/manage/images/pdf/097326f9db0697ef9a6707fc97fd2468.pdf Accessed: 08 October 2020
  4. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/manage/images/pdf/097326f9db0697ef9a6707fc97fd2468.pdf Accessed: 08 October 2020
  5. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:203 https://www.imsociety.org/manage/images/pdf/097326f9db0697ef9a6707fc97fd2468.pdf Accessed: 08 October 2020
  6. Menopause Glossary: V – Vasomotor Symptoms. North American Menopause Society https://www.menopause.org/for-women/menopause-glossary Accessed: 08 October 2020
  7. De Villiers, T. J., Gass, M. L. S., Haines, C. J., Hall, J. E., Lobo, R. A., Pierroz, D. D. and Rees, M. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric, 2013;16:204 https://www.imsociety.org/manage/images/pdf/097326f9db0697ef9a6707fc97fd2468.pdf Accessed: 08 October 2020
  8. De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT. Climacteric, 2016;19:4:314 https://www.imsociety.org/manage/images/pdf/ba6379e868044bec13015ac2b84f2753.pdf Accessed: 08 October 2020

Topic Last Updated: 08 October 2020 – Topic Last Reviewed: 08 October 2020
Print Friendly, PDF & Email